Clopidogrel and ticlopidine are agents that irreversibly inhibit adenosine diphosphate (ADP)–
induced platelet aggregation. 1 Interaction of ADP with the P2Y1 receptor of the platelet …

BACKGROUND AND PURPOSE: Clopidogrel and aspirin are antiplatelet medications used
in patients intended for endovascular stent placement. Although various studies have …

BACKGROUND AND PURPOSE: Antiplatelet therapy is associated with decreased ischemic
events after neurointerventional procedures. Antiplatelet resistance negates the protective …

In the context of neurointerventional procedures, clopidogrel hyper-responsiveness has
been associated with hemorrhage; on the other hand, clopidogrel resistance has been …

The secondary prevention of ischemic stroke is aided by the use of antiplatelet therapy, and
the predominant current choices are aspirin, aspirin plus extended-release dipyridamole …

Two recent papers have evaluated the safety and efficacy of prasugrel in suspected
clopidogrel non-responders in the neurointerventional population. 1 2 In both papers the …

Clopidogrel is an inhibitor of platelet aggregation, indicated for the prevention of ischemic
stroke and in-stent thrombosis. However, it has a number of drawbacks, including an …

Clopidogrel is an effective antiplatelet agent and is useful in the prevention of stroke,
myocardial infarction, and related vascular death in patients with vascular disease …

Background: As clopidogrel is being increasingly used, intracerebral hemorrhage (ICH)
associated with clopidogrel are expected to increase. We assessed the prevalence and …

A 50-year-old male with hypertension, insulin-dependent diabetes mellitus, hyperlipidemia,
and obstructive sleep apnea presented with left hemiplegia, hemisensory loss, and …